D. E. Shaw & Co., Inc. Omeros Corp Call Options Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OMER
# of Institutions
120Shares Held
25.6MCall Options Held
228KPut Options Held
630K-
Ingalls & Snyder LLC New York, NY4.54MShares$35.1 Million0.7% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$31.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$25.2 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$14.7 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.34MShares$10.4 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $485M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...